{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T10:21:28Z","timestamp":1783592488009,"version":"3.55.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T00:00:00Z","timestamp":1605744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T00:00:00Z","timestamp":1605744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["19ek0109295H0003"],"award-info":[{"award-number":["19ek0109295H0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"JSPS KAKENHI","award":["15H04886"],"award-info":[{"award-number":["15H04886"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Loss-of-function mutations in the interleukin (IL)-36 gene <jats:italic>IL36RN<\/jats:italic> are associated with psoriasis. The importance of neutrophil extracellular traps (NETs), web-like structures composed of neutrophil DNA, in the pathogenesis of psoriasis has been unclear. Here, we aimed to clarify the role of NET signaling in the deficiency of IL36 receptor antagonist (DITRA). We evaluated the severity of psoriasis-like lesions induced by imiquimod cream treatment in <jats:italic>Il36rn<\/jats:italic><jats:sup>\u2212\/\u2212<\/jats:sup> mice. The mRNA levels of psoriasis-related cytokines were measured via real-time reverse transcription polymerase chain reaction, and the effects of Cl-amidine, a peptidyl arginine deiminase 4 (PAD4) inhibitor, on psoriasis-like lesions were evaluated. PAD4 is a histone-modifying enzyme that is involved in NET formation. Psoriasis area and severity index scores, epidermal thickness, and infiltrated neutrophil counts were significantly increased in <jats:italic>Il36rn<\/jats:italic><jats:sup>\u2212\/\u2212<\/jats:sup> mice; NET formation was confirmed pathologically. Several cytokines and chemokines were upregulated in the skin lesions of <jats:italic>Il36rn<\/jats:italic><jats:sup>\u2212\/\u2212<\/jats:sup> mice and Cl-amidine treatment improved these psoriasis-like lesions. These results suggest that NET formation plays an important role in the pathology of psoriasis-like lesions in these mice and might represent a promising therapeutic target for DITRA.<\/jats:p>","DOI":"10.1038\/s41598-020-76864-y","type":"journal-article","created":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T11:03:51Z","timestamp":1605783831000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Neutrophil extracellular traps are induced in a psoriasis model of interleukin-36 receptor antagonist-deficient mice"],"prefix":"10.1038","volume":"10","author":[{"given":"Soichiro","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidehiko","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihito","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurie","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumitsu","family":"Sugiura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,19]]},"reference":[{"key":"76864_CR1","doi-asserted-by":"publisher","first-page":"13677","DOI":"10.1074\/jbc.M400117200","volume":"279","author":"JE Towne","year":"2004","unstructured":"Towne, J. E., Garka, K. E., Renshaw, B. R., Virca, G. D. & Sims, J. E. Interleukin (IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-kappaB and MAPKs. J. Biol. Chem. 279, 13677\u201313688 (2004).","journal-title":"J. Biol. Chem."},{"key":"76864_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ni1110-973","volume":"11","author":"C Dinarello","year":"2010","unstructured":"Dinarello, C. et al. IL-1 family nomenclature. Nat. Immunol. 11, 1\u20133 (2010).","journal-title":"Nat. Immunol."},{"key":"76864_CR3","doi-asserted-by":"publisher","first-page":"6053","DOI":"10.4049\/jimmunol.1301481","volume":"192","author":"AM Foster","year":"2014","unstructured":"Foster, A. M. et al. IL-36 promotes myeloid cell infiltration, activation and inflammatory activity in skin. J. Immunol. 192, 6053\u20136061 (2014).","journal-title":"J. Immunol."},{"key":"76864_CR4","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1056\/NEJMoa1013068","volume":"365","author":"S Marrakchi","year":"2011","unstructured":"Marrakchi, S. et al. Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. N. Engl. J. Med. 365, 620\u2013628 (2011).","journal-title":"N. Engl. J. Med."},{"key":"76864_CR5","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.ajhg.2011.07.022","volume":"89","author":"A Onoufriadis","year":"2011","unstructured":"Onoufriadis, A. et al. Mutations in IL36RN\/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis. Am. J. Hum. Genet. 89, 432\u2013437 (2011).","journal-title":"Am. J. Hum. Genet."},{"key":"76864_CR6","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1038\/jid.2013.230","volume":"133","author":"K Sugiura","year":"2013","unstructured":"Sugiura, K. et al. The majority of generalized pustular psoriasis without psoriasis vulgaris is caused by deficiency of interleukin-36 receptor antagonist. J. Invest. Dermatol. 133, 2514\u20132521 (2013).","journal-title":"J. Invest. Dermatol."},{"key":"76864_CR7","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jdermsci.2014.02.006","volume":"74","author":"K Sugiura","year":"2014","unstructured":"Sugiura, K. The genetic background of generalized pustular psoriasis: IL36RN mutations and CARD14 gain-of-function variants. J. Dermatol. Sci. 74, 187\u2013192 (2014).","journal-title":"J. Dermatol. Sci."},{"key":"76864_CR8","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jdermsci.2018.01.012","volume":"90","author":"M Akiyama","year":"2018","unstructured":"Akiyama, M., Takeichi, T., McGrath, J. A. & Sugiura, K. Autoinflammatory keratinization diseases: An emerging concept encompassing various inflammatory keratinization disorders of the skin. J. Dermatol. Sci. 90, 105\u2013111 (2018).","journal-title":"J. Dermatol. Sci."},{"key":"76864_CR9","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/j.jaci.2017.05.019","volume":"140","author":"M Akiyama","year":"2017","unstructured":"Akiyama, M., Takeichi, T., McGrath, J. A. & Sugiura, K. Autoinflammatory keratinization diseases. J. Allergy Clin. Immunol. 140, 1545\u20131547 (2017).","journal-title":"J. Allergy Clin. Immunol."},{"key":"76864_CR10","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jaut.2017.01.007","volume":"80","author":"A Shibata","year":"2017","unstructured":"Shibata, A. et al. Toll-like receptor 4 antagonist TAK-242 inhibits autoinflammatory symptoms in DITRA. J. Autoimmun. 80, 28\u201338 (2017).","journal-title":"J. Autoimmun."},{"key":"76864_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-56847-4","volume":"10","author":"H Fukushima","year":"2020","unstructured":"Fukushima, H. et al. TAK-242 ameliorates contact dermatitis exacerbate by IL-36 receptor antagonist deficiency. Sci. Rep. 10, 1\u201310 (2020).","journal-title":"Sci. Rep."},{"key":"76864_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-56847-4","volume":"10","author":"K Saito","year":"2020","unstructured":"Saito, K. et al. IL-36 receptor antagonist deficiency resulted in delayed wound healing due to excessive recruitment of immune cells. Sci. Rep. 10, 1\u201312 (2020).","journal-title":"Sci. Rep."},{"key":"76864_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0194667","volume":"13","author":"J Palomo","year":"2018","unstructured":"Palomo, J., Troccaz, S., Talabot-Aye, D., Rodriguez, E. & Palmer, G. The severity of imiquimod-induced mouse skin inflammation is independent of endogenous IL-38 expression. PLoS ONE 13, 1\u201315 (2018).","journal-title":"PLoS ONE"},{"key":"76864_CR14","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1172\/JCI63451","volume":"122","author":"L Tortola","year":"2012","unstructured":"Tortola, L. et al. Psoriasiform dermatitis is driven by IL-36\u2013mediated DC-keratinocyte crosstalk. J. Clin. Invest. 122, 3965\u20133976 (2012).","journal-title":"J. Clin. Invest."},{"key":"76864_CR15","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1172\/JCI92217","volume":"127","author":"S Bagchi","year":"2017","unstructured":"Bagchi, S. et al. CD1b-autoreactive T cells contribute to hyperlipidemia-induced skin inflammation in mice. J. Clin. Invest. 127, 2339\u20132352 (2017).","journal-title":"J. Clin. Invest."},{"key":"76864_CR16","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.jaci.2015.10.046","volume":"13","author":"P Di Meglio","year":"2016","unstructured":"Di Meglio, P. et al. Targeting CD8(+) T cells prevents psoriasis development. J. Allergy Clin. Immunol. 13, 274\u2013276 (2016).","journal-title":"J. Allergy Clin. Immunol."},{"key":"76864_CR17","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1111\/bjd.16596","volume":"178","author":"B Kirby","year":"2018","unstructured":"Kirby, B. Langerhans cells in psoriasis: Getting to the core of the disease. Br. J. Dermatol. 178, 1240 (2018).","journal-title":"Br. J. Dermatol."},{"key":"76864_CR18","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1172\/JCI27180","volume":"116","author":"H Wang","year":"2006","unstructured":"Wang, H. et al. Activated macrophages are essential in a murine model for T cell-mediated chronic psoriasiform skin inflammation. J. Clin. Invest. 116, 2105\u20132114 (2006).","journal-title":"J. Clin. Invest."},{"key":"76864_CR19","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","volume":"386","author":"WH Boehncke","year":"2015","unstructured":"Boehncke, W. H. & Sch\u00f6n, M. P. Psoriasis. Lancet 386, 983\u2013994 (2015).","journal-title":"Lancet"},{"key":"76864_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2019.00001","volume":"10","author":"S Shao","year":"2019","unstructured":"Shao, S. et al. Neutrophil extracellular traps promote inflammatory responses in psoriasis via activating epidermal TLR4\/IL-36R crosstalk. Front.. Immunol. 10, 1\u201314 (2019).","journal-title":"Front.. Immunol."},{"key":"76864_CR21","first-page":"1","volume":"361","author":"J Park","year":"2016","unstructured":"Park, J. et al. Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps. Sci. Transl. Med. 361, 1\u201321 (2016).","journal-title":"Sci. Transl. Med."},{"key":"76864_CR22","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.4049\/jimmunol.0902199","volume":"184","author":"MF Denny","year":"2010","unstructured":"Denny, M. F. et al. A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs. J. Immunol. 184, 3284\u20133297 (2010).","journal-title":"J. Immunol."},{"key":"76864_CR23","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.chom.2013.01.005","volume":"13","author":"CN Jenne","year":"2013","unstructured":"Jenne, C. N. et al. Neutrophils recruited to sites of infection protect from virus challenge by releasing neutrophil extracellular traps. Cell Host Microbe 13, 169\u2013180 (2013).","journal-title":"Cell Host Microbe"},{"key":"76864_CR24","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nm.1959","volume":"15","author":"K Kessenbrock","year":"2009","unstructured":"Kessenbrock, K. et al. Netting neutrophils in autoimmune small-vessel vasculitis. Nat. Med. 15, 623\u2013625 (2009).","journal-title":"Nat. Med."},{"key":"76864_CR25","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1152\/physrev.00012.2018","volume":"99","author":"PX Liew","year":"2018","unstructured":"Liew, P. X. & Kubes, P. The Neutrophil\u2019s role during health and disease. Physiol. Rev. 99, 1223\u20131248 (2018).","journal-title":"Physiol. Rev."},{"key":"76864_CR26","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ebiom.2016.07.012","volume":"10","author":"K Okubo","year":"2016","unstructured":"Okubo, K. et al. Lactoferrin suppresses neutrophil extracellular traps release in inflammation. EBioMedicine 10, 204\u2013215 (2016).","journal-title":"EBioMedicine"},{"key":"76864_CR27","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1172\/JCI84538","volume":"126","author":"OE S\u00f8rensen","year":"2016","unstructured":"S\u00f8rensen, O. E. & Borregaard, N. Neutrophil extracellular traps - the dark side of neutrophils. J. Clin. Invest. 126, 1612\u20131620 (2016).","journal-title":"J. Clin. Invest."},{"key":"76864_CR28","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/nri.2017.105","volume":"18","author":"V Papayannopoulos","year":"2018","unstructured":"Papayannopoulos, V. Neutrophil extracellular traps in immunity and disease. Nat. Rev. Immunol. 18, 134\u2013147 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"76864_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-016-0001-8","volume":"6","author":"SC Hu","year":"2016","unstructured":"Hu, S. C. et al. Neutrophil extracellular trap formation is increased in psoriasis and induces human beta- defensin-2 production in epidermal keratinocytes. Sci. Rep. 6, 1\u201314 (2016).","journal-title":"Sci. Rep."},{"key":"76864_CR30","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.4049\/jimmunol.1202388","volume":"190","author":"JM Kahlenberg","year":"2013","unstructured":"Kahlenberg, J. M., Carmona-Rivera, C., Smith, C. K. & Kaplan, M. J. Neutrophil extracellular trap-associated protein activation of the NLRP3 inflammasome is enhanced in lupus macrophages. J. Immunol. 190, 1217\u20131226 (2013).","journal-title":"J. Immunol."},{"key":"76864_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2020.01137","volume":"11","author":"MR Scheenstra","year":"2020","unstructured":"Scheenstra, M. R., van Harten, R. M., Veldhuizen, E. J. A., Haagsman, H. P. & Coorens, M. Cathelicidinsmodulate TLR-activation andinflammation. Front. Immunol. 11, 1\u201316 (2020).","journal-title":"Front. Immunol."},{"key":"76864_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-017-0012-9","volume":"9","author":"L Chen","year":"2018","unstructured":"Chen, L. et al. Neutrophil extracellular traps promote macrophage pyroptosis in sepsis. Cell Death Dis. 9, 1\u201312 (2018).","journal-title":"Cell Death Dis."},{"key":"76864_CR33","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1111\/febs.14075","volume":"284","author":"DM Clancy","year":"2017","unstructured":"Clancy, D. M., Henry, C. M., Sullivan, G. P. & Martin, S. J. Neutrophil extracellular traps can serve as platforms for processing and activation of IL-1 family cytokines. FEBS J. 284, 1712\u20131725 (2017).","journal-title":"FEBS J."},{"key":"76864_CR34","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.celrep.2015.12.072","volume":"14","author":"CM Henry","year":"2016","unstructured":"Henry, C. M. et al. Neutrophil-derived proteases escalate inflammation through activation of il-36 family cytokines. Cell Rep. 14, 708\u2013722 (2016).","journal-title":"Cell Rep."},{"key":"76864_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2018.00001","volume":"9","author":"Y Chen","year":"2018","unstructured":"Chen, Y. et al. Esculetin ameliorates psoriasis-like skin disease in mice by including CD4+Foxp3+ regulatory T cells. Front. Immunol. 9, 1\u201313 (2018).","journal-title":"Front. Immunol."},{"key":"76864_CR36","doi-asserted-by":"publisher","first-page":"700","DOI":"10.2174\/1389450116666150202160954","volume":"16","author":"EE Witalison","year":"2015","unstructured":"Witalison, E. E., Thompson, P. R. & Hofseth, L. J. Protein Arginine Deiminases and associated citrullination: Physiological functions and diseases associated with dysregulation. Curr Drug Targets. 16, 700\u2013710 (2015).","journal-title":"Curr Drug Targets."},{"key":"76864_CR37","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/bip.22127","volume":"99","author":"KL Bicker","year":"2013","unstructured":"Bicker, K. L. & Thompson, P. R. The protein arginine deiminases (PADs): Structure, function, inhibition, and disease. Biopolymers 99, 155\u2013163 (2013).","journal-title":"Biopolymers"},{"key":"76864_CR38","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1084\/jem.20100239","volume":"207","author":"P Li","year":"2010","unstructured":"Li, P. et al. PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J. Exp. Med. 207, 1853\u20131862 (2010).","journal-title":"J. Exp. Med."},{"key":"76864_CR39","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nm.4294","volume":"7","author":"SK Jorch","year":"2017","unstructured":"Jorch, S. K. & Kubes, P. An emerging role for neutrophil extracellular traps in noninfectious disease. Nat. Med. 7, 279\u2013287 (2017).","journal-title":"Nat. Med."},{"key":"76864_CR40","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1016\/j.jid.2019.04.020","volume":"139","author":"J Di Domizio","year":"2019","unstructured":"Di Domizio, J. & Gilliet, M. Psoriasis caught in the NET. J. Invest. Dermatol. 139, 1426\u20131429 (2019).","journal-title":"J. Invest. Dermatol."},{"key":"76864_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2019.01162","volume":"10","author":"AL Buhl","year":"2019","unstructured":"Buhl, A. L. & Wenzel, J. Interleukin-36 in infectious and inflammatory skin diseases. Front. Immunol. 10, 1\u201311 (2019).","journal-title":"Front. Immunol."},{"key":"76864_CR42","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/cei.12761","volume":"184","author":"MA Boutet","year":"2016","unstructured":"Boutet, M. A. et al. Distinct expression of interleukin (IL)-36a, b and c, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn\u2019s disease. Clin. Exp. Immunol. 184, 159\u2013173 (2016).","journal-title":"Clin. Exp. Immunol."},{"key":"76864_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.26508\/lsa.202000688","volume":"3","author":"JD Goldstein","year":"2020","unstructured":"Goldstein, J. D. et al. IL-36 signaling in keratinocytes controls early IL-23 production in psoriasis-like dermatitis. Life Sci Alliance. 3, 1\u201318 (2020).","journal-title":"Life Sci Alliance."},{"key":"76864_CR44","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.immuni.2009.08.001","volume":"31","author":"CE Sutton","year":"2009","unstructured":"Sutton, C. E. et al. Interleukin-1 and IL-23 induce innate IL-17 production from \u03b3\u03b4 T cells, amplifying Th17 responses and autoimmunity. Immunity 31, 331\u2013341 (2009).","journal-title":"Immunity"},{"key":"76864_CR45","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1046\/j.1523-1747.2000.00936.x","volume":"114","author":"A Ishida-Yamamoto","year":"2000","unstructured":"Ishida-Yamamoto, A. et al. Decreased deiminated keratin K1 in psoriatic hyperproliferative epidermis. J. Invest. Dermatol. 114, 701\u2013705 (2000).","journal-title":"J. Invest. Dermatol."},{"key":"76864_CR46","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jdermsci.2006.07.004","volume":"44","author":"S Chavanas","year":"2006","unstructured":"Chavanas, S. et al. Peptidylarginine deiminases and deimination in biology and pathology: Relevance to skin homeostasis. J. Dermatol. Sci. 44, 63\u201372 (2006).","journal-title":"J. Dermatol. Sci."},{"key":"76864_CR47","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671\u2013675 (2012).","journal-title":"Nat. Methods"},{"key":"76864_CR48","first-page":"1","volume":"14","author":"X Zhang","year":"2008","unstructured":"Zhang, X., Goncalves, R. & Mosser, D. M. The isolation and characterization of murine macrophages. Curr. Protoc. Immunol. 14, 1\u201318 (2008).","journal-title":"Curr. Protoc. Immunol."},{"key":"76864_CR49","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jdermsci.2018.08.010","volume":"92","author":"R Safi","year":"2018","unstructured":"Safi, R. et al. Neutrophils contribute to vasculitis by increased release of neutrophil extracellular traps in Beh\u00e7et\u2019s disease. J. Dermatol. Sci. 92, 143\u2013150 (2018).","journal-title":"J. Dermatol. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-76864-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-76864-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-76864-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T23:50:40Z","timestamp":1670370640000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-76864-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,19]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["76864"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-76864-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,19]]},"assertion":[{"value":"7 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20149"}}